PL322876A1 - Pik type kinase of cellular cycle control point: materials and methods - Google Patents

Pik type kinase of cellular cycle control point: materials and methods

Info

Publication number
PL322876A1
PL322876A1 PL96322876A PL32287696A PL322876A1 PL 322876 A1 PL322876 A1 PL 322876A1 PL 96322876 A PL96322876 A PL 96322876A PL 32287696 A PL32287696 A PL 32287696A PL 322876 A1 PL322876 A1 PL 322876A1
Authority
PL
Poland
Prior art keywords
pik
materials
methods
control point
cycle control
Prior art date
Application number
PL96322876A
Inventor
Merl F Hoekstra
Doug Holtzman
Kathleen S Keegan
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Publication of PL322876A1 publication Critical patent/PL322876A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL96322876A 1995-11-16 1996-11-18 Pik type kinase of cellular cycle control point: materials and methods PL322876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55866695A 1995-11-16 1995-11-16
US73129696A 1996-02-27 1996-02-27
US72530496A 1996-10-21 1996-10-21

Publications (1)

Publication Number Publication Date
PL322876A1 true PL322876A1 (en) 1998-03-02

Family

ID=27415779

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96322876A PL322876A1 (en) 1995-11-16 1996-11-18 Pik type kinase of cellular cycle control point: materials and methods

Country Status (6)

Country Link
CN (1) CN1199420A (en)
AU (1) AU1461197A (en)
IL (1) IL121306A0 (en)
NO (1) NO973279L (en)
PL (1) PL322876A1 (en)
WO (1) WO1997018323A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
US5777093A (en) * 1995-05-16 1998-07-07 Ramot-University Authority For Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
GB9518220D0 (en) * 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
WO1999002653A1 (en) * 1997-07-11 1999-01-21 Trustees Of The University Of Pennsylvania Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
GB9714971D0 (en) 1997-07-16 1997-09-24 Cancer Res Campaign Tech Assays,therapeutic methods and means
GB9718952D0 (en) * 1997-09-05 1997-11-12 Medical Res Council Mammalian chk1 effector cell cycle checkpoint protein kinase materials and methods
CA2216559A1 (en) * 1997-09-25 1999-03-25 Michel Roberge G2 checkpoint inhibitors and assay
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
US6071691A (en) * 1998-04-27 2000-06-06 Oregon Health Science University Materials and methods for modulating differentiation
US6387640B1 (en) 1999-02-10 2002-05-14 St. Jude Children's Research Hospital ATM kinase modulation for screening and therapies
US6348311B1 (en) * 1999-02-10 2002-02-19 St. Jude Childre's Research Hospital ATM kinase modulation for screening and therapies
US6670167B1 (en) 1999-11-01 2003-12-30 Agouron Pharmaceuticals, Inc. Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
US20040142894A1 (en) * 2002-10-25 2004-07-22 Stein Gary S. Modulation of cellular proliferation
BRPI0413467A (en) 2003-08-13 2006-10-17 Kudos Pharm Ltd aminopyrones and their use as inhibitors of atm
US7402607B2 (en) 2004-09-20 2008-07-22 Kudos Pharmaceuticals Limited DNA-PK inhibitors
JP2008529995A (en) 2005-02-09 2008-08-07 クドス ファーマシューティカルズ リミテッド ATM inhibitor
AR053358A1 (en) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd DNA INHIBITORS - PK

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518220D0 (en) * 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene

Also Published As

Publication number Publication date
NO973279L (en) 1997-09-16
CN1199420A (en) 1998-11-18
WO1997018323A3 (en) 1997-10-09
NO973279D0 (en) 1997-07-15
AU1461197A (en) 1997-06-05
IL121306A0 (en) 1998-01-04
WO1997018323A2 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
HUP0002474A3 (en) Improved anti-ige antibodies and method of improving polypeptides
IL123161A0 (en) Flameless heater and method of making same
HUP9900422A3 (en) Novel protein and methods for the production of the same
IL124376A0 (en) Stable avidin composition and method using same
PL315914A1 (en) Haemopoesive protein as well as method of and materials for obtaining same
IL130683A0 (en) Gypsum wallboard and method of making same
PL334200A1 (en) Superabsorptive material and method of making same
PL313633A1 (en) Ceramid type compounds, method of obtaining them and their application
ZA964733B (en) Ob protein compositions and methods
HU9601650D0 (en) Translucent polycrystalline alumina and method of making same
PL323723A1 (en) Novel derivatives of dolastatin, their production and application
EP0738891A3 (en) A method of detecting protein and a kit using the same
AU6577898A (en) Structural element and method of making
IL121306A0 (en) Cell cycle checkpoint pik-related kinase materials and methods
HUP9602510A1 (en) Preparation of substituted thiazoles
AP9701131A0 (en) Wall construction and method of manufacturing
EG21286A (en) Blends of organosillane compounds and their use
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
HUP0201701A2 (en) Hobble turning method and preferred applications of said method
GB9723231D0 (en) Mammalian CHK1 effectro cell-cycle checkpoint protein kinase materials and methods
PL338431A1 (en) Coating material and method of obtaining same
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
PL340487A1 (en) Macaroni and method of making same
HUP9801062A3 (en) A kinase anchoring protein and uses thereof
PL328680A1 (en) Container and method of manufacturing same